A potential explanation for this difference in association is that NfL is a better marker for monitoring disease progression while its value does not lie in predicting future cognitive decline.4 Differences could also be related to the fact that clinical progression to MCI or dementia is a binary outcome measure, while MMSE decline is a continuous measure with possibly a higher degree of measurement variation. This evidence concerns the gene NEFL and dementia.